The firm had posted a net loss at Rs 2.96 cr in corresponding quarter of the previous financial year
Total income up 7.5% to Rs 811 cr; gross NPAs rise to 2.01% from 1.91% a year earlier
Chairman Arundhati Bhattacharya says bank benefiting from economic recovery
Total income jumped 58% to Rs 2,864 cr
Sales for the period stood at Rs 54,802 crores
Firm had said last month profits would be hit due to integration with Ranbaxy, remedial action at plants under USFDA scanner
Total income surges to Rs 4,788 cr in the quarter under review
Company reports strong bottomline due to sharp fall in expenditure, increased other income
The company incurred one-time exceptional charges of Rs 685.17 crore related to write-downs and integration of Ranbaxy
Revenue from pharmacy grows 36% to Rs 520 cr
Net profit more than doubles to Rs 763 crore, helped by one-time gain of Rs 158 crore
Company plans Rs 650 crore investment in 2015
Financial performance came on the back of improved margins in its coal trading, mine development and agro business
Net sales of the company rose to Rs 2,532.08 crore during the first quarter, up 7.37%
Gross NPA rises to 4.29% from 4.25% on a quarter-on-quarter basis
Tepid loan growth, provision for NPAs, bond portfolio make dent
Total revenue grew 15% but revenue from US declined 21%
Sales rise 152% to Rs 47 cr
However, consolidated net profit for the quarter was Rs 29.61 cr, on a total income of Rs 468.15 cr
The company registered a 2% rise in its net income from operations during the period to Rs 3,190 cr